April 21, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreApril 21, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreMay 18, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreApril 21, 2026
Market insights predict, the drug discovery as a service industry is expected to grow from USD 21.3 billion in 2024 to USD 79.82 billion by 2034, driven by a CAGR of 14.17%. The drug discovery as a service market is expanding due to increasing cancer occurrence as well as growing drug discoveries for chronic diseases. North America led the market d...
April 21, 2026
According to market projections, the healthcare supply chain management sector is expected to grow from USD 3.60 billion in 2025 to USD 10.27 billion by 2035, reflecting a CAGR of 11.05%. The market is growing due to the increasing demand for operational efficiency and cost reduction in healthcare organizations. Additionally, the integration of adv...
April 21, 2026
Based on market forecasts, the mRNA therapeutics CDMO sector will expand from USD 4.62 billion in 2024 to USD 13.63 billion by 2034, experiencing a CAGR of 11.37%.The growing demand for vaccines and the rising prevalence of chronic disorders drive the market. The availability of state-of-the-art research and development facilities and increasing go...
April 21, 2026
Market insights predict the global medical foods for orphan disease industry will increase from USD 8.84 billion in 2024 to USD 14.65 billion by 2034, achieving a CAGR of 5.2%. The market is growing due to rising health awareness, demand for personalized nutrition, and increased focus on rare disease treatments. Advances in biotechnology and suppor...
April 21, 2026
Projections indicate that, the global cell & gene therapy quality control market will increase from USD 2.28 billion in 2024 to USD 22.81 billion by 2034, experiencing a CAGR of 25.74% over the next 10 years.The cell & gene therapy quality control market is growing due to it plays a significant role in ensuring that any cell or gene therapy...
April 21, 2026
According to market projections, the global bio-based propylene glycol market, valued at USD 289.25 million in 2024, is anticipated to reach USD 837.57 million by 2034, growing at a CAGR of 11.25% over the next decade. The growing new drug discovery research and the growing demand for natural excipients drive the global market. North America domina...
April 21, 2026
Market insights predict the global non-sterile compounding pharmacy industry will increase from USD 5.97 billion in 2024 to USD 12.11 billion by 2034, achieving a CAGR of 7.34%. The rise in OTC drug demand is driving the non-sterile compounding pharmacy market. North America dominates due to the strong presence of pharmaceutical key players. ...
April 21, 2026
Market insights predict, the investigational new drug CDMO industry is expected to grow from USD 5.66 billion in 2025 to USD 11.10 billion by 2035, driven by a CAGR of 6.97%. The investigational new drug CDMO market is expanding due to increasing developments in industries as well as growing cancer treatment approaches. North America led the market...
April 21, 2026
Based on market forecasts, the global advanced therapy medicinal products CDMO market, projected at USD 6.73 billion in 2024, is expected to reach USD 37.27 billion by 2034, growing at a CAGR of 18.82% over the forecast period. The global market is driven by an increase in the pipeline of ATMP candidates in clinical trials, necessary the growth of ...
April 21, 2026
Market insights predict, the veterinary CRO and CDMO industry is expected to grow from USD 7.17 billion in 2024 to USD 16.13 billion by 2034, driven by a CAGR of 8.43%. The market is growing due to rising pet ownership and increased focus on animal health. Pharma companies are outsourcing R&D and manufacturing to reduce costs and speed up produ...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
